See more : Cypark Resources Berhad (5184.KL) Income Statement Analysis – Financial Results
Complete financial analysis of Boai NKY Medical Holdings Ltd. (300109.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Boai NKY Medical Holdings Ltd., a leading company in the Drug Manufacturers – General industry within the Healthcare sector.
- Pasofino Gold Limited (VEIN.V) Income Statement Analysis – Financial Results
- Pure H20 Bio-Technologies, Inc. (PRHB) Income Statement Analysis – Financial Results
- Japan Medical Dynamic Marketing, INC. (JMDMF) Income Statement Analysis – Financial Results
- Trex Company, Inc. (TREX) Income Statement Analysis – Financial Results
- Hephaestus Holdings Limited (8173.HK) Income Statement Analysis – Financial Results
Boai NKY Medical Holdings Ltd. (300109.SZ)
About Boai NKY Medical Holdings Ltd.
Boai NKY Medical Holdings Ltd. develops, manufactures, and sells polyvinylpyrrolidone (PVP) series products worldwide. The company offers KoVidone and PolyKoVidone line of products representing Povidone, Crospovidone, and Copovidone pharmaceutical excipients; OraRez line of PVM/MA copolymer and derivatives representing functional polymers for bioadhesive/mucoadhesive applications; KoVidone-1 broad spectrum biocidal, antifungal, and antiviral agents; and pharmaceutical solvents and intermediates. It also offers polymers, vinyl and vinyl ether compounds, PolyViscol, KoVidone I, WhiVidone, and PVPP. Its products are used in pharma, industrial, oral care, cosmetics, food and beverage, and other sectors. The company was formerly known as Boai NKY Pharmaceuticals Ltd. and changed its name to NKY medical holding Ltd. in March 2016. Boai NKY Medical Holdings Ltd. was founded in 1987 and is based in Heping, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.58B | 1.49B | 1.22B | 978.53M | 924.43M | 698.28M | 488.58M | 400.62M | 290.64M | 253.34M | 209.39M | 212.85M | 190.73M | 163.31M | 130.09M | 108.68M | 83.44M |
| Cost of Revenue | 689.03M | 795.06M | 727.41M | 548.62M | 484.00M | 381.75M | 256.64M | 221.49M | 167.72M | 176.51M | 151.85M | 165.83M | 140.34M | 112.82M | 91.19M | 78.00M | 62.82M |
| Gross Profit | 894.39M | 690.63M | 492.86M | 429.90M | 440.42M | 316.54M | 231.94M | 179.13M | 122.92M | 76.84M | 57.54M | 47.02M | 50.40M | 50.49M | 38.90M | 30.68M | 20.62M |
| Gross Profit Ratio | 56.48% | 46.49% | 40.39% | 43.93% | 47.64% | 45.33% | 47.47% | 44.71% | 42.29% | 30.33% | 27.48% | 22.09% | 26.42% | 30.92% | 29.90% | 28.23% | 24.71% |
| Research & Development | 63.71M | 65.73M | 75.53M | 70.27M | 49.29M | 51.09M | 32.76M | 21.51M | 12.75M | 7.99M | 7.56M | 7.44M | 8.35M | 7.54M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 33.54M | 30.95M | 60.14M | 52.27M | 46.94M | 26.02M | 18.97M | 11.05M | 10.24M | 7.27M | 5.10M | 3.24M | 3.26M | 3.13M | 12.03M | 7.15M | 5.38M |
| Selling & Marketing | 67.55M | 65.20M | 71.90M | 69.75M | 60.54M | 46.49M | 34.69M | 25.12M | 16.31M | 12.90M | 12.45M | 9.97M | 8.89M | 8.02M | 4.87M | 4.62M | 3.25M |
| SG&A | 101.09M | 96.15M | 132.04M | 122.02M | 107.47M | 72.50M | 53.67M | 36.16M | 26.55M | 20.17M | 17.55M | 13.21M | 12.16M | 11.15M | 16.90M | 11.77M | 8.62M |
| Other Expenses | 144.36M | 93.10M | 125.69M | 78.48M | 51.78M | -1.51M | 2.03M | 2.61M | 963.98K | 204.11K | 1.13M | 2.07M | 2.35M | 3.18M | 385.27K | -107.70K | -55.74K |
| Operating Expenses | 309.15M | 254.98M | 333.27M | 270.77M | 208.55M | 164.34M | 115.81M | 82.16M | 57.14M | 40.71M | 33.41M | 27.32M | 26.75M | 24.33M | 17.65M | 12.20M | 9.10M |
| Cost & Expenses | 998.18M | 1.05B | 1.06B | 819.40M | 692.55M | 546.08M | 372.45M | 303.64M | 224.86M | 217.21M | 185.26M | 193.15M | 167.09M | 137.15M | 108.84M | 90.20M | 71.92M |
| Interest Income | 13.59M | 23.53M | 48.40M | 5.58M | 2.56M | 901.89K | 2.94M | 7.99M | 393.79K | 41.97K | 93.63K | 1.46M | 4.10M | 425.75K | 54.44K | 48.21K | 16.18K |
| Interest Expense | 2.99M | 2.62M | 37.73M | 51.56M | 48.95M | 33.59M | 3.47M | 6.04M | 1.16M | 451.94K | 27.06K | 365.87K | 588.02K | 1.29M | 1.79M | 2.10M | 1.94M |
| Depreciation & Amortization | 76.94M | 65.84M | 76.20M | 56.27M | 46.28M | 40.95M | 36.41M | 32.40M | 24.08M | 19.21M | 9.59M | 7.12M | 7.12M | 5.55M | 3.96M | 3.10M | 2.74M |
| EBITDA | 665.29M | 460.50M | 409.02M | 171.05M | 250.71M | 178.12M | 147.91M | 135.27M | 92.86M | 54.61M | 32.96M | 30.37M | 36.61M | 33.45M | 26.66M | 18.99M | 13.73M |
| EBITDA Ratio | 42.02% | 36.35% | 47.63% | 21.88% | 30.31% | 27.95% | 31.68% | 34.81% | 32.10% | 22.08% | 16.02% | 14.47% | 19.36% | 20.96% | 19.80% | 19.29% | 17.22% |
| Operating Income | 585.24M | 388.67M | 400.21M | 161.62M | 237.16M | 106.82M | 106.57M | 92.50M | 66.07M | 34.89M | 22.22M | 20.83M | 26.54M | 23.43M | 20.57M | 13.90M | 9.20M |
| Operating Income Ratio | 36.96% | 26.16% | 32.80% | 16.52% | 25.66% | 15.30% | 21.81% | 23.09% | 22.73% | 13.77% | 10.61% | 9.79% | 13.92% | 14.35% | 15.81% | 12.79% | 11.03% |
| Total Other Income/Expenses | 124.81K | -203.36K | 6.83M | -94.60M | -78.40M | -1.51M | 2.03M | 2.08M | 963.98K | 204.11K | 1.13M | 2.05M | 2.35M | 3.18M | 368.30K | -2.63M | -1.72M |
| Income Before Tax | 585.36M | 388.47M | 402.86M | 67.02M | 158.76M | 105.32M | 108.60M | 94.55M | 67.04M | 35.10M | 23.35M | 22.88M | 28.90M | 26.60M | 20.94M | 13.79M | 9.15M |
| Income Before Tax Ratio | 36.97% | 26.15% | 33.01% | 6.85% | 17.17% | 15.08% | 22.23% | 23.60% | 23.07% | 13.85% | 11.15% | 10.75% | 15.15% | 16.29% | 16.10% | 12.69% | 10.97% |
| Income Tax Expense | 99.57M | 107.04M | 121.96M | 34.38M | 33.02M | 14.73M | 15.96M | 14.32M | 10.05M | 4.98M | 3.18M | 2.81M | 3.97M | 3.58M | 2.73M | 3.44M | 2.89M |
| Net Income | 493.03M | 291.46M | 293.12M | 32.64M | 122.80M | 89.55M | 92.82M | 80.04M | 56.99M | 30.12M | 20.17M | 20.07M | 24.92M | 23.03M | 18.21M | 10.35M | 6.26M |
| Net Income Ratio | 31.14% | 19.62% | 24.02% | 3.34% | 13.28% | 12.82% | 19.00% | 19.98% | 19.61% | 11.89% | 9.63% | 9.43% | 13.07% | 14.10% | 14.00% | 9.52% | 7.50% |
| EPS | 1.02 | 0.59 | 0.43 | 0.09 | 0.30 | 0.27 | 0.28 | 0.24 | 0.22 | 0.13 | 0.09 | 0.13 | 0.17 | 0.20 | 0.17 | 0.13 | 0.20 |
| EPS Diluted | 0.97 | 0.57 | 0.41 | 0.09 | 0.30 | 0.27 | 0.28 | 0.24 | 0.22 | 0.13 | 0.09 | 0.13 | 0.17 | 0.20 | 0.17 | 0.13 | 0.20 |
| Weighted Avg Shares Out | 483.72M | 514.32M | 500.96M | 477.76M | 409.32M | 327.65M | 331.51M | 333.36M | 259.38M | 226.79M | 219.19M | 154.05M | 147.81M | 115.57M | 106.39M | 81.02M | 31.43M |
| Weighted Avg Shares Out (Dil) | 506.00M | 514.32M | 500.96M | 477.76M | 409.32M | 327.65M | 331.51M | 333.36M | 259.38M | 226.79M | 219.19M | 154.05M | 147.81M | 115.57M | 106.39M | 81.02M | 31.43M |
Source: https://incomestatements.info
Category: Stock Reports